Aeon

ECONOMIC DEVELOPMENT INITIATIVE, COMMUNITY PROJECT FUNDING, AND MISCELLANEOUS GRANTS

SYSTEM FOR INCREASING PATIENT ACCESS TO EYE EXAMS FOR DIABETIC RETINOPATHY

INHALATION REPURPOSING OF AN APPROVED DRUG TO TREAT SEVERE ASTHMA - PROJECT SUMMARY THE BUSINESS OBJECTIVE OF AEON RESPIRE, AND THE PURPOSE OF THIS SBIR PROJECT, IS TO EXECUTE KEY STEPS TOWARDS REPURPOSING NICLOSAMIDE AS A NEW ASTHMA TREATMENT. THE THERAPEUTIC RATIONALE FOR THESE STUDIES IS BASED ON INITIAL FINDINGS THAT NICLOSAMIDE INHIBITS AN ION CHANNEL THAT IS PIVOTAL FOR AIRWAY SMOOTH MUSCLE CONTRACTION AND MUCIN HYPERSECRETION. BOTH OF THESE PATHOLOGIC PROCESSES CONTRIBUTE TO AIRWAY NARROWING AND ARE CONSIDERED, IN ADDITION TO INFLAMMATION, AS THE CORE FEATURES OF ASTHMA. EXISTING MEDICATIONS FAIL TO ADEQUATELY RELIEVE AIRWAY NARROWING IN MORE SEVERE, TREATMENT REFRACTORY PATIENTS. IN PARTICULAR, THE EFFICACY OF INHALED BETA-AGONISTS IS COMPROMISED AT A CELLULAR LEVEL BY BOTH REPEAT USE DESENSITIZATION AND THE INDIRECT EFFECTS OF INFLAMMATION. THEREFORE, THERE IS NEED FOR NEW TREATMENT APPROACHES. TMEM16A IS A CALCIUM-ACTIVATED CHLORIDE CHANNEL THAT REGULATES CALCIUM SIGNALING IN THE AIRWAYS AND IS REQUIRED FOR AIRWAY SMOOTH MUSCLE CONTRACTION. NICLOSAMIDE IS AN FDA-APPROVED ORAL DRUG ORIGINALLY DISCOVERED DECADES AGO AND SAFELY USED AS AN ANTI-HELMINTH. IT WAS RECENTLY IDENTIFIED IN A HIGH THROUGHPUT UNBIASED SCREEN AS A SPECIFIC TMEM16A INHIBITOR. NICLOSAMIDE FULLY RELAXES CONTRACTED AIRWAYS VIA THIS MECHANISM AND RESISTS DESENSITIZATION PATHWAYS THAT UNDERMINE THE EFFECTIVENESS OF BETA-AGONISTS. IT ALSO REDUCES MUCIN RELEASE INDUCED BY ASTHMA- ASSOCIATED ACTIVATION SIGNALS. TMEM16A INHIBITION WITH REPURPOSED NICLOSAMIDE IS THEREFORE AN ATTRACTIVE NEW ASTHMA TREATMENT APPROACH AND WILL BENEFIT FROM THE DRUG’S ESTABLISHED HUMAN SAFETY RECORD. NICLOSAMIDE, HOWEVER, HAS POOR BIOAVAILABILITY AND IS UNLIKELY TO REACH TMEM16A IN THE AIRWAYS THROUGH ORAL DOSING. THE FIRST OBJECTIVE OF THE PROJECT IS TO REFORMULATE NICLOSAMIDE THROUGH PARTICLE ENGINEERING TO ENABLE INHALED DOSING. THE NEXT OBJECTIVE IS TO USE THE NEW FORMULATION IN INHALATION STUDIES TO CONFIRM THE DRUG REACHES ITS TARGET LOCALLY AND WILL OPEN AIRWAYS PROVOKED BY A CONTRACTILE AGENT. ADDITIONAL STUDIES WILL ESTABLISH THE PHARMACOKINETIC AND INITIAL TOXICOLOGIC PROFILE OF INHALED NICLOSAMIDE. THESE STUDIES ARE CRUCIAL TO TEST THE SCIENTIFIC HYPOTHESIS THAT INHIBITING TMEM16A IN THE AIRWAYS IS A SAFE AND EFFECTIVE APPROACH TO OPEN OBSTRUCTED AIRWAYS. THEY ALSO REPRESENT IMPORTANT STEPS REQUIRED TO MOVE THE PROJECT CLOSER TO DISCUSSIONS WITH THE FDA, FILING AN IND AND TESTING IN HUMAN STUDIES.

LOW COST DEVICE FOR DETECTION OF RETINAL DISEASE

VISUAL ACUITY AND FUNCTIONAL MEASUREMENTS IN THE AGING EYE - PROJECT SUMMARY AGE-RELATED MACULAR DEGENERATION (AMD) REMAINS THE MOST COMMON CAUSE OF PERMANENT VISION LOSS IN THE US AND MANY INDUSTRIALIZED COUNTRIES. DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA ARE THE LEADING CAUSE OF VISUAL ACUITY LOSS IN WORKING AGE AMERICANS. VISUAL FUNCTION IS A KEY COMPONENT IN ALMOST ALL OF THE 1,861 US CLINICAL TRIALS FOR AMD AND 262 FOR DIABETIC RETINOPATHY AND MACULAR EDEMA. IF OUTCOME MEASURES, INCLUDING VISUAL ACUITY, COULD BE MADE MORE ACCURATE AND COST-EFFECTIVE AND WITH DECREASED TEST-RETEST VARIABILITY, THEN CLINICAL TRIALS COULD USE SMALLER SAMPLE SIZES, GIVING SAVINGS IN COST AND TIME TO BRING THERAPIES TO MARKET. BY BUILDING A NEW DEVICE, THE POTENTIAL VISION TESTER™ (PVT), WE WILL IMPROVE MEASUREMENTS BY MINIMIZING THE ISSUES FROM THE OPTICS OF THE AGING EYE. SIMULTANEOUS RETINAL IMAGING WILL CLARIFY FIXATION LOCUS AND FIXATION STABILITY OF THE PATIENT’S EYE. THE OPTICAL ERRORS OF A PATIENT’S EYE WILL BE MEASURED AS WAVEFRONT ABERRATIONS, AND THE TARGET DISPLAY WILL BE CORRECTED WITH MODERATELY PRICED ADAPTIVE OPTICS TO OVERCOME RETINAL ELEVATION FROM EXUDATION AS WELL AS REFRACTIVE ERROR. REPORTING OUT OF WAVEFRONT ERRORS DISTINGUISHES BETWEEN NEURAL DAMAGE VS. OPTICAL ISSUES. A HIGH RESOLUTION DISPLAY, SUITABLE FOR VISUAL ACUITY TESTING, WILL PROJECT STIMULI ONTO THE EYE IN MAXWELLIAN VIEW TO MINIMIZE PUPIL SIZE EFFECTS FOUND IN OLDER EYES. COMPETING DEVICES FOR MICROPERIMETRY LACK THE RESOLUTION NEEDED FOR VISUAL ACUITY. WE WILL USE PSYCHOPHYSICAL TECHNIQUES THAT ARE RAPID, ACCURATE, AND PROVIDE BETTER MEASURES OF VARIABILITY: 4 ALTERNATIVE FORCED CHOICE. IN AIM 1, WE WILL BUILD AN ADAPTIVE OPTICS-CORRECTED PVT VISUAL DISPLAY AND NIR ILLUMINATION FOR RETINAL IMAGING. THE IMAGING LIGHT IS COMFORTABLE AND DIM ENOUGH NOT TO INTERFERE WITH VISUAL TASKS. THE PATENTED NIR IMAGING TECHNOLOGY PROJECTS A SERIES OF STRIPES ONTO THE RETINA IN A RASTER PATTERN, PROVIDING LINE SCANNING FOR IMAGING. THE DETECTION IS VIA A 2D CMOS DETECTOR WITH A ROLLING SHUTTER, WITH THE SERIAL READ-OUT OF THE LINES EITHER SYNCHRONIZED WITH THE ILLUMINATION OR OFFSET IN TIME. THIS PROVIDES A FLEXIBLE ELECTRONIC APERTURE UNDER COMPUTER CONTROL. BOTH CONFOCAL AND MULTIPLY SCATTERED LIGHT IMAGES ARE AVAILABLE, REVEALING DRUSEN AND OTHER SUBRETINAL THICKENING. WE WILL OPTIMIZE IMAGE QUALITY IN 10 SUBJECTS WITH A RANGE OF REFRACTIVE ERROR, OCULAR PIGMENTATION, AND AGE. IN AIM 2, WE WILL QUANTIFY AND VALIDATE THE HARTMANN-SHACK WAVEFRONT MEASUREMENTS OF THE PVT IN 20 PATIENTS WITH RETINAL DISEASE VS. 20 WITHOUT TO DETERMINE THE EFFECT ON WAVEFRONT MEASUREMENTS. IN AIM 3 WE WILL OPTIMIZE THE ALGORITHM FOR EFFICIENT TESTING AND METRIC FOR POTENTIAL VISUAL ACUITY (PVA), USING DATA FROM AIMS 1 AND 2, REPORTING CENTRAL TENDENCY (EXPECTED VALUE) AND VARIABILITY, INCLUDING OPTICAL ERRORS AND FIXATION DATA, TO ADDRESS THE ACUITY THIS PATIENT COULD REACH WITH RETINAL TREATMENT. IN AIM 4, FOR 20 PATIENTS WITH EXUDATIVE AMD AND 20 WITH DIABETIC MACULAR EDEMA, WE WILL ASSESS PVA REPRODUCIBILITY AND VALIDITY BY COMPARISON TO STANDARD VA AND THE PREDICTION AT BASELINE TO ACTUAL POST-TREATMENT MEASURED VA AND PVA AT FOLLOW UP.

CONFOCAL AND AUTOFLUORESCENCE IMAGING OF MACULAR DEGENERATION USING A LOW COST DIGITAL IMAGER

SBIR PHASE I: AN ULTRA-FAST BATTERY CHARGER FOR ELECTRIC VEHICLES

PURPOSE: THE CONTINUUM OF CARE (COC) PROGRAM IS DESIGNED TO PROMOTE COMMUNITY-WIDE COMMITMENT TO THE GOAL OF ENDING HOMELESSNESS; PROVIDE FUNDING FOR EFFORTS BY NONPROFIT PROVIDERS, STATES, AND LOCAL GOVERNMENTS TO QUICKLY HOUSE HOMELESS INDIVIDUALS AND FAMILIES WHILE MINIMIZING THE TRAUMA AND DISLOCATION CAUSED TO HOMELESS INDIVIDUALS, FAMILIES, AND COMMUNITIES BY HOMELESSNESS; PROMOTE ACCESS TO AND EFFECTIVE UTILIZATION OF MAINSTREAM PROGRAMS BY HOMELESS INDIVIDUALS AND FAMILIES; AND OPTIMIZE SELF-SUFFICIENCY AMONG INDIVIDUALS AND FAMILIES EXPERIENCING HOMELESSNESS. THE MOST RECENT COC AWARD ANNOUNCEMENT LISTING AWARDS BY STATE AND COC IS ACCESSIBLE AT HTTPS://WWW.HUD.GOV/PROGRAM_OFFICES/COMM_PLANNING/COC/AWARDS. SELECT THE LINK UNDER THE FUNDING AND AWARD INFORMATION SECTION FOR THE APPROPRIATE FISCAL YEAR.; ACTIVITIES TO BE PERFORMED: CONTINUUM OF CARE PROGRAM FUNDS MAY BE USED TO PAY FOR THE ELIGIBLE COSTS USED TO ESTABLISH AND OPERATE PROJECTS UNDER FIVE PROGRAM COMPONENTS: (1) PERMANENT HOUSING, WHICH INCLUDES PERMANENT SUPPORTIVE HOUSING FOR PERSONS WITH DISABILITIES, AND RAPID REHOUSING; (2) TRANSITIONAL HOUSING; (3) SUPPORTIVE SERVICES ONLY; (4) HOMELESS MANAGEMENT INFORMATION SYSTEMS (HMIS), AND (5) IN SOME CASES, HOMELESSNESS PREVENTION. THIRTEEN TYPES OF ASSISTANCE MAY BE PROVIDED THROUGH THE CONTINUUM OF CARE (COC) PROGRAM: (1) COC PLANNING ACTIVITIES/COSTS FOR DESIGNING AND CARRYING OUT A COLLABORATIVE PROCESS FOR THE DEVELOPMENT OF AN APPLICATION TO HUD; (2) UNITED FUNDING AGENCY (UFA) COSTS FOR FISCAL CONTROL AND ACCOUNTING NECESSARY TO ASSURE THE PROPER DISBURSAL OF, AND ACCOUNTING FOR, FEDERAL FUNDS AWARDED TO SUBRECIPIENTS UNDER THE CONTINUUM OF CARE PROGRAM, (3) ACQUISITION OF REAL PROPERTY (INCLUDING STRUCTURES) FOR USE IN THE PROVISION OF HOUSING OR SUPPORTIVE SERVICES; (4) REHABILITATION OF STRUCTURES TO PROVIDE HOUSING OR SUPPORTIVE SERVICES; (5) NEW CONSTRUCTION, INCLUDING THE BUILDING OF A NEW STRUCTURE OR BUILDING AN ADDITION TO AN EXISTING STRUCTURE FOR USE AS SUPPORTIVE HOUSING; (6) LEASING OF A STRUCTURE OR STRUCTURES, OR PORTIONS THEREOF, TO PROVIDE HOUSING OR SUPPORTIVE SERVICES; (7) RENTAL ASSISTANCE, WHICH MAY BE SHORT-TERM, MEDIUM-TERM, OR LONG-TERM, AS WELL AS TENANT-BASED, PROJECT-BASED, OR SPONSOR-BASED, FOR TRANSITIONAL OR PERMANENT HOUSING; (8) SUPPORTIVE SERVICES TO ASSIST PROGRAM PARTICIPANTS OBTAIN AND MAINTAIN HOUSING; (9) OPERATING COSTS OF SUPPORTIVE HOUSING; (10) COSTS OF IMPLEMENTING AND OPERATING HMIS; (11) PROJECT ADMINISTRATIVE COSTS; (12) RELOCATION COSTS; AND (13) INDIRECT COSTS IN ACCORDANCE WITH 2 CFR PARTS 200, AS APPLICABLE. IN ADDITION TO USING GRANT FUNDS FOR THE ELIGIBLE COSTS DESCRIBED ABOVE, RECIPIENTS AND SUBRECIPIENTS IN CONTINUUMS OF CARE DESIGNATED AS HIGH PERFORMING COMMUNITIES MAY ALSO USE GRANT FUNDS TO PROVIDE HOUSING RELOCATION AND STABILIZATION SERVICES AND SHORT- AND/OR MEDIUM-TERM RENTAL ASSISTANCE TO INDIVIDUALS AND FAMILIES AT RISK OF HOMELESSNESS AS SET FORTH IN 24 CFR 576.103 AND 24 CFR 576.104, IF NECESSARY TO PREVENT THE INDIVIDUAL OR FAMILY FROM BECOMING HOMELESS. LIMITATION ON USE OF FUNDS: NO ASSISTANCE PROVIDED UNDER PROGRAM (OR ANY STATE OR LOCAL GOVERNMENT FUNDS USED TO SUPPLEMENT THIS ASSISTANCE) MAY BE USED TO REPLACE STATE OR LOCAL FUNDS PREVIOUSLY USED, OR DESIGNATED FOR USE, TO ASSIST HOMELESS PERSONS OR PERSONS AT-RISK OF HOMELESSNESS.; EXPECTED OUTCOMES: DECREASE IN THE NUMBER INDIVIDUALS AND FAMILIES EXPERIENCING HOMELESSNESS, MORE SPECIFICALLY USING PERFORMANCE INDICATORS SUCH AS THE LENGTH OF TIME HOMELESS, RETURNS TO HOMELESSNESS OVER TIME, AND EXITS TO PERMANENT HOUSING. COC PERFORMANCE PROFILE REPORTS CAN BE FOUND AT HTTPS://WWW.HUDEXCHANGE.INFO/PROGRAMS/COC/COC-PERFORMANCE-PROFILE-REPORTS/.; INTENDED BENEFICIARIES: INDIVIDUALS AND FAMILIES EXPERIENCING HOMELESSNESS.; SUBRECIPIENT ACTIVITIES: THE SUBRECIPIENT ACTIVITIES ARE UNKNOWN AT THE TIME OF AWARD.

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

CONTINUUM OF CARE PROGRAM

VISUAL ACUITY AND FUNCTIONAL MEASUREMENTS IN THE AGING EYE

COST-EFFECTIVE OCT DETECTION OF VISION-THREATENING MACULAR EDEMA

CONFOCAL AND AUTOFLUORESCENCE IMAGING OF MACULAR DEGENERATION USING A LOW COST DI

TISSUE OXYGENATION IN SMALL RETINAL VESSELS

CONTINUUM OF CARE PROGRAM

LOWERING THE COST OF IMAGING FOR RETINAL MICROVASCULATURE IN DIABETIC PATIENTS

CONTINUUM OF CARE PROGRAM

PORTABLE RETINAL IMAGING DEVICE FOR URGENT REFERRALS AND REMOTE TREATMENT

LOW COST DEVICE FOR DETECTION OF RETINAL DISEASE

ASSISTIVE DEVICE TO IMPROVE OBJECT RECOGNITION AND READING

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

CONTINUUM OF CARE PROGRAM

HOMELESS ASSISTANCE

HOMELESS ASSISTANCE

PURPOSE: THE CONTINUUM OF CARE (COC) PROGRAM IS DESIGNED TO PROMOTE COMMUNITY-WIDE COMMITMENT TO THE GOAL OF ENDING HOMELESSNESS; PROVIDE FUNDING FOR EFFORTS BY NONPROFIT PROVIDERS, STATES, AND LOCAL GOVERNMENTS TO QUICKLY HOUSE HOMELESS INDIVIDUALS AND FAMILIES WHILE MINIMIZING THE TRAUMA AND DISLOCATION CAUSED TO HOMELESS INDIVIDUALS, FAMILIES, AND COMMUNITIES BY HOMELESSNESS; PROMOTE ACCESS TO AND EFFECTIVE UTILIZATION OF MAINSTREAM PROGRAMS BY HOMELESS INDIVIDUALS AND FAMILIES; AND OPTIMIZE SELF-SUFFICIENCY AMONG INDIVIDUALS AND FAMILIES EXPERIENCING HOMELESSNESS. THE MOST RECENT COC AWARD ANNOUNCEMENT LISTING AWARDS BY STATE AND COC IS ACCESSIBLE AT HTTPS://WWW.HUD.GOV/PROGRAM_OFFICES/COMM_PLANNING/COC/AWARDS. SELECT THE LINK UNDER THE FUNDING AND AWARD INFORMATION SECTION FOR THE APPROPRIATE FISCAL YEAR.; ACTIVITIES TO BE PERFORMED: CONTINUUM OF CARE PROGRAM FUNDS MAY BE USED TO PAY FOR THE ELIGIBLE COSTS USED TO ESTABLISH AND OPERATE PROJECTS UNDER FIVE PROGRAM COMPONENTS: (1) PERMANENT HOUSING, WHICH INCLUDES PERMANENT SUPPORTIVE HOUSING FOR PERSONS WITH DISABILITIES, AND RAPID REHOUSING; (2) TRANSITIONAL HOUSING; (3) SUPPORTIVE SERVICES ONLY; (4) HOMELESS MANAGEMENT INFORMATION SYSTEMS (HMIS), AND (5) IN SOME CASES, HOMELESSNESS PREVENTION. THIRTEEN TYPES OF ASSISTANCE MAY BE PROVIDED THROUGH THE CONTINUUM OF CARE (COC) PROGRAM: (1) COC PLANNING ACTIVITIES/COSTS FOR DESIGNING AND CARRYING OUT A COLLABORATIVE PROCESS FOR THE DEVELOPMENT OF AN APPLICATION TO HUD; (2) UNITED FUNDING AGENCY (UFA) COSTS FOR FISCAL CONTROL AND ACCOUNTING NECESSARY TO ASSURE THE PROPER DISBURSAL OF, AND ACCOUNTING FOR, FEDERAL FUNDS AWARDED TO SUBRECIPIENTS UNDER THE CONTINUUM OF CARE PROGRAM, (3) ACQUISITION OF REAL PROPERTY (INCLUDING STRUCTURES) FOR USE IN THE PROVISION OF HOUSING OR SUPPORTIVE SERVICES; (4) REHABILITATION OF STRUCTURES TO PROVIDE HOUSING OR SUPPORTIVE SERVICES; (5) NEW CONSTRUCTION, INCLUDING THE BUILDING OF A NEW STRUCTURE OR BUILDING AN ADDITION TO AN EXISTING STRUCTURE FOR USE AS SUPPORTIVE HOUSING; (6) LEASING OF A STRUCTURE OR STRUCTURES, OR PORTIONS THEREOF, TO PROVIDE HOUSING OR SUPPORTIVE SERVICES; (7) RENTAL ASSISTANCE, WHICH MAY BE SHORT-TERM, MEDIUM-TERM, OR LONG-TERM, AS WELL AS TENANT-BASED, PROJECT-BASED, OR SPONSOR-BASED, FOR TRANSITIONAL OR PERMANENT HOUSING; (8) SUPPORTIVE SERVICES TO ASSIST PROGRAM PARTICIPANTS OBTAIN AND MAINTAIN HOUSING; (9) OPERATING COSTS OF SUPPORTIVE HOUSING; (10) COSTS OF IMPLEMENTING AND OPERATING HMIS; (11) PROJECT ADMINISTRATIVE COSTS; (12) RELOCATION COSTS; AND (13) INDIRECT COSTS IN ACCORDANCE WITH 2 CFR PARTS 200, AS APPLICABLE. IN ADDITION TO USING GRANT FUNDS FOR THE ELIGIBLE COSTS DESCRIBED ABOVE, RECIPIENTS AND SUBRECIPIENTS IN CONTINUUMS OF CARE DESIGNATED AS HIGH PERFORMING COMMUNITIES MAY ALSO USE GRANT FUNDS TO PROVIDE HOUSING RELOCATION AND STABILIZATION SERVICES AND SHORT- AND/OR MEDIUM-TERM RENTAL ASSISTANCE TO INDIVIDUALS AND FAMILIES AT RISK OF HOMELESSNESS AS SET FORTH IN 24 CFR 576.103 AND 24 CFR 576.104, IF NECESSARY TO PREVENT THE INDIVIDUAL OR FAMILY FROM BECOMING HOMELESS. LIMITATION ON USE OF FUNDS: NO ASSISTANCE PROVIDED UNDER PROGRAM (OR ANY STATE OR LOCAL GOVERNMENT FUNDS USED TO SUPPLEMENT THIS ASSISTANCE) MAY BE USED TO REPLACE STATE OR LOCAL FUNDS PREVIOUSLY USED, OR DESIGNATED FOR USE, TO ASSIST HOMELESS PERSONS OR PERSONS AT-RISK OF HOMELESSNESS.; EXPECTED OUTCOMES: DECREASE IN THE NUMBER INDIVIDUALS AND FAMILIES EXPERIENCING HOMELESSNESS, MORE SPECIFICALLY USING PERFORMANCE INDICATORS SUCH AS THE LENGTH OF TIME HOMELESS, RETURNS TO HOMELESSNESS OVER TIME, AND EXITS TO PERMANENT HOUSING. COC PERFORMANCE PROFILE REPORTS CAN BE FOUND AT HTTPS://WWW.HUDEXCHANGE.INFO/PROGRAMS/COC/COC-PERFORMANCE-PROFILE-REPORTS/.; INTENDED BENEFICIARIES: INDIVIDUALS AND FAMILIES EXPERIENCING HOMELESSNESS.; SUBRECIPIENT ACTIVITIES: THE SUBRECIPIENT ACTIVITIES ARE UNKNOWN AT THE TIME OF AWARD.

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

CONTINUUM OF CARE PROGRAM

SEC 9007 REAP-RENEW ENERGY SYSTEMS GRANTS, $20,000 OR LESS (MAN)